AbbVie Can't Escape Investors' Humira Kickbacks Suit
An Illinois federal judge Tuesday refused to toss an AbbVie Inc. investor class action alleging that the pharmaceutical company concealed its use of an illegal strategy to market its blockbuster drug...To view the full article, register now.
Already a subscriber? Click here to view full article